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Encephalomyocarditis virus (EMCV) and Theiler's murine encepha-
litis virus (TMEV) are species in the Cardiovirus genus of the
Picornaviridae family. Like all picornaviruses, the 7.8 kb positive-
sense RNA genomes encode single, large open reading frames (~2200
aa). Viral translation is mediated through a cap-independent type II
internal ribosome entry site (IRES) located immediately 5' of the open
reading frame. The encoded polyprotein is cleaved by viral proteases
in co-translational and post-translational reactions to produce a
spectrum of mature viral proteins and partially processed precursors
(Hahn and Palmenberg, 1996; Palmenberg, 1990; Parks et al., 1989).
The mature proteins and their precursors are named according to
their sequential locations in the polyprotein. The P1 region includes
3–4 viral capsid proteins (e.g. 1A, 1B, 1C and 1D). The P2 and P3
regions include multiple nonstructural proteins (2B, 2C, 3A, 3B, 3Cpro,
3Dpol), conserved among the viruses and responsible for RNA
replication (Rueckert and Wimmer, 1984). Unique to the genome
organization of each picornavirus genus are variable length Leader
proteins (L) encoded 5’ of P1 region, and 2A proteins at the N-
terminus of the P2 region. The L and 2A, separately or in combination,provide key virus anti-host activities and/or primary polyprotein
cleavage activities, producing distinct and characteristic patterns
of polyprotein processing, particularly with regard to initial co-
translational cleavages. For cardioviruses, the primary scission
reaction between 2A and 2B, is carried out by a monomolecular
ribosome skippingmechanism dependent on the C-terminal 18 amino
acids of 2A (Hahn and Palmenberg, 2001). Subsequent cleavage by
viral 3Cpro (from P3 region) produces the majority of secondary
polyprotein cleavages (Palmenberg, 1990; Parks and Palmenberg,
1987), including scissions between L/P1 and P1/2A (Jackson, 1986).
Since picornaviral translation is cap-independent by virtue of the 5’
IRES, many of these viruses have evolved potent mechanisms to inhibit
cellular cap-dependent translation during infection, thereby thwarting
detrimental antiviral responses. The enteroviruses and aphthoviruses,
for example, encode secondary proteases at their 2A and L positions
respectively, which target eIF4G (Guarné et al., 1998; Lloyd et al., 1988),
an essential scaffolding protein for the assembly of cap-dependent eIF4F
complexes. Normally, within eIF4F, the eIF4G bridges interactions
between eIF4E (cap-binding protein), eIF4A (an RNA helicase) and the
incoming 40S ribosomal subunit (Gingras et al., 1999). Cleavage of this
factor precludes productive association of capped mRNAs with pre-
initiation complexes, preventing their translation.
Cardioviruses do not have secondary proteases. Their L and 2A
proteins have essential host shut-off roles, but use non-proteolytic
mechanisms to achieve them. The EMCV L (67 aa) contributes to the
inhibition of cap-dependent translation by triggering dramatic
disruption of nucleocytoplasmic trafﬁcking during infection. The
Leader binds Ran-GTPase, an essential trafﬁcking control regulator.
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nucleoporins (Nups) in the central nuclear pore (NPC) transport
channel as well as additional phosphorylation events on regulatory
proteins throughout the cell (Lidsky et al., 2006; Porter and
Palmenberg, 2009; Ricour et al., 2009 ). As a consequence, all active
nuclear import and export, including that of nascent cellular mRNAs is
stopped, and only very small molecules and proteins (N50 kDa) can
still exchange by passive diffusion through the NPC. In the absence of
L, or before it exerts effects on Nup phosphorylation, protein/RNA
transport back and forth across the NPC is signal-dependent
(NLS) and requires interaction with importin/exportin receptors
(karyopherins) to chaperone trafﬁc (Fahrenkrog and Aebi, 2003;
Gorlich and Kutay, 1999; Stewart and Semler, 1997). Classical NLS
sequences, epitomized by the SV40 T antigen, contain one or more
contiguous motifs, highly enriched in positively charged residues.
Other NLS sequences can be bipartite (e.g. nucleophosmin), or more
hydrophobic, such as the monpartite c-myc NLS or the NLS of the
hnRNP K protein (Mattaj and Englmeier, 1998). Regardless of the
speciﬁc sequence, NLS-mediated binding with cognate karyopherins,
deﬁnes a cargo's destination (in or out) and can even deﬁne its
subcellular localization (e.g. nucleolus). Our current model of EMCV L
activity proposes that Nup phosphorylation prevents shuttling of
karyopherins. The consequence of this inhibition is that nuclear
proteins are not replenished in the nucleus and only large proteins
which can't diffuse, or which are anchored to chromatin, remain
nuclear and do not efﬂux into equilibrium with the cytoplasm. The
consequence of unregulated relocalization affects availability of
multiple translation and transcription factors, helping to abrogate
many critical host antiviral functions.
The cardiovirus 2A protein is not required for L-dependent NPC
shutoff. Yet it plays an ancillary, albeit poorly understood role in
support of cellular translational shutoff. The protein is small (17 kDa),
and in contrast to L (pI ~3.2) is highly basic (pI ~10.3). There is no
overt sequence similarity to other database proteins and only limited
motif-dependent sequence conservation among various strains of
cardioviruses (Fig. 2). From the earliest times after infection, EMCV 2A
accumulates in nucleoli, where it associates with nascent ribosomal
RNA (Aminev et al., 2003b). A smaller cytoplasmic pool of 2A
transiently associates with 40S ribosomal subunits, in reactions
that correlate with the appearance of excess 80S monosomes in
cells and a concomitant decrease in polysome abundance (Groppo
and Palmenberg, 2007). These unusual 80S are virtually devoid of
cellular (but not viral) mRNA. When 2A is expressed in cells in the
absence of infection, it subtly modulates the cellular translational
environment in an unknown manner, to increase the ratio of IRES-
dependent translation to cap-dependent translation of reporter
constructs. Deletions within EMCV 2A, in a viral context, prevent
the initial polyprotein cleavage (requires the C-terminal 18 amino
acids) (Hahn and Palmenberg, 1996, 2001) and are reported to affect
the phosphorylation status of eIF4E binding protein 1 (4E-BP1) during
Mengo infection of BHK cells (Svitkin et al., 1998). This is an important
ﬁnding because hypo-phosphorylated 4E-BP1 is a direct competitor of
eIF4G binding to eIF4E, suggesting that cardioviruses, like aphtho- and
enterovirusesmay similarly identify eIF4G and/or its interactionswith
eIF4E as a vulnerable targets in their respective host translation
shutoff mechanisms. In the absence of infection, the competitive
reactions between eIF4G (translation turned on) and 4E-BP1
(translation turned off) are mediated by common surface motifs of
the format, YXXXXLΦ, whereΦ is a hydrophobic amino acid (Rhoads,
2009). Since these proteins cannot interact simultaneously with
eIF4E, the competition regulates cap-dependent translation activity
according to the needs of the cell. Given this functional context, it was
of great interest to recognize the same motif near the C-terminus of
every cardiovirus 2A protein. We now report for EMCV, this motif
indeed binds eIF4E, and moreover, that a nearby 2A NLS sequence is
required for virus shutoff of cap-dependent host protein synthesis.Results
2A localization during infection
HeLa cells infected with vEC9, a recombinant EMCV-R with a
shortened poly C tract (Hahn and Palmenberg, 1995), were examined
for the localization of 2A relative to cell stains for membrane lectins
(WGA) and DNA (DAPI). Consistent with previous experiments in L
cells (Aminev et al., 2003b) the earliest 2A signals (0–3 h) became
visible as small punctuate nuclear speckles, proceeding to deﬁnite
nucleolar accumulation after about 3 h PI (Fig. 1A). During the log
phase of viral replication (3–6 h PI), nucleoli consistently displayed
bright, steady 2A signals, while the more diffuse cytoplasmic signals
also continued to build. Cell lysis initiates at 6–8 h PI under these
infection conditions. The relative nuclear/cytoplasmic 2A distribu-
tions described by multiple microscopy trials were conﬁrmed by
subcellular fractionation and quantitative Western analyses (data not
shown).
2A sequence motifs
Aligned cardiovirus 2A protein sequences share less than 58%
identity for the genus as a whole and only 88% and 82% within
the EMCV and TMEV species, respectively. The 2A structure has not
been resolved, but sequence-based prediction algorithms suggest
the COOH half of these proteins (Fig. 2) have strong alpha-
helicalpropensities, particularly within the terminal 18 amino acids
required to achieve co-translational polyprotein scission (Hahn and
Palmenberg, 1996, 2001). Terminal NPG/P-type ribosome skipping
elements are common to many genera of picornaviruses (Atkins et al.,
2007), but unique to the cardioviruses, a short segment within the
required element (vEC9, aa 126–134), ﬁts the proﬁle of YXXXXLΦ
binding motifs used by eIF4G and 4E-BP proteins to interact with
eIF4E (Rhoads, 2009). About 30 amino acids N-terminal to this
segment, cardiovirus 2A proteins also display short, highly basic
segments, consistent with general consensus required for (yeast)
ribosomal protein nuclear localization (YRP-NLS). In yeast this
sequence directs cargo entry into the nucleus but typically is not
sufﬁcient for nucleolar localization (NoLS), a targeting destination
where a universal consensus sequence is much harder to deﬁne by
bioinformatics (Gritz et al., 1985; Moreland et al., 1985; Schaap et al.,
1991; Underwood and Fried, 1990).
eIF4E pull-down experiments
The ability of vEC9 2A to bind eIF4E in vivowas tested in pull-down
assays with anti-eIF4E antibodies linked to agarose beads. After
appropriate lysates were reacted with the beads, the bound proteins
were fractionated by SDS-PAGE then identiﬁed by Western analyses
(Fig. 3A). As expected, eIF4E itself reacted with the beads regardless of
whether the lysates came from infected or uninfected cells. Likewise,
some eIF4G was captured as predicted for a primary binding partner
of eIF4E. A portion of the 2A protein was also brought down with
beads exposed to infected cell lysates. We have reported a minor
fraction of 2A typically associates with 40S ribosome subunits during
infection (Groppo and Palmenberg, 2007). To rule out the possibility
the 2A pull-down signal was due to eIF4E-linked ribosomes, an
antibody to the small ribosome subunit protein S6, was included
among the probes. No S6was associatedwith the beads, indicating the
2A detected by this assay was not from ribosome contaminants and
that our bead-washing procedures were sufﬁciently stringent.
In the preferred format of pull-down experiments, reciprocal
antibodies are used to cross-test and conﬁrm interactions. But when
mAb-2A was coupled to beads, reacted with lysates and boiled to
release the proteins, the IgG light chain (27 kDa) masked potential
signals from eIF4E (27 kDa), rendering the results inconclusive (data
Fig. 1. 2A localization. A. Infected (vEC9) HeLa cells were harvested at the indicated
times, ﬁxed and stained for 2A (red), membranes (WGA, green) and DNA (DAPI, blue).
Images of all stains are merged. B. HeLa cells were infected with the indicated viruses
(MOI of 30), ﬁxed (4 h PI) and stained for 2A (green), membranes (WGA, red), and DNA
(DAPI, blue). Right image column shows all stains (merged). Left column show 2A stain
only.
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and 2A the tests were repeated using 7meGTP beads, a 5’ cap mimic, as
an alternate method for capturing eIF4E. As with antibody-mediated
pull-downs, proteins associated with eIF4E were also captured
(Fig. 3B), but they were not captured equivalently by control beads
bound to GMP (Fig. 3C), since eIF4E does not react with theunmodiﬁed nucleotide (Marcotrigiano et al., 1999). In agreement
with Fig. 3A, eIF4E and 2A (when present)were extracted from lysates
only with the 7meGTP beads. The absence of S6 and 4E-BP1 among the
resin-bound signals indicates the captured 2A was not mediated by
eIF4E-bound ribosomes or by indirect 2A:4E-BP1 interactions.
eIF4E binding motif mutations
If the conserved segment near the COOH terminus of 2A is re-
sponsible, mutagenic interference should disrupt eIF4E binding.
Single (L134A) and double (LI134AA) substitution mutations were
engineered into this motif within a vEC9 context (Fig. 4A). The
resultant viruses grewmore slowly than vEC9, requiring ~35 and 48 h,
respectively, to achieve plaques similar to wild-type at 29 h PI
(Fig. 6A). The mutations were stable throughout virus growth and did
not revert (sequencing not shown). Infected cell extracts harboring
the wild-type or mutant 2A proteins were retested in assays with the
α-eIF4E beads (Fig. 4B) and with the 7meGTP beads (Fig. 4C).
Predictable, eIF4E and eIF4G were again extracted from all samples.
The 2A from vEC9-infected lysates also bound both sets of resins. The
L134A and LI134AA proteins, although synthesized in their respective
lysates and detectable byWesterns (Fig. 4B) were not extracted by the
eIF4E resin (Fig. 4B). The 7meGTP beads showed some (lower)
reactivity with L134A but none with LI134AA (Fig. 4C). Again, the
results are consistent with reduced eIF4E binding by the mutant 2A
proteins relative to wild-type. Therefore, the 2A region impacted by
these mutations must contribute to the ability of eIF4E to pull down
2A.
While such experiments provide effective assessments of mutual
afﬁnities, they do not provide overtly quantitative measures of
binding stoichiometries. Over the course of multiple such experi-
ments, including those shown here, we found eIF4E and eIF4G were
typically extracted with approximately equivalent Western signals,
regardless of the source of starting lysate (mock or infected). But
variability between experiments and in bead saturation levels made it
difﬁcult to concludewhether 2A (vEC9)was augmenting or displacing
any eIF4E:eIF4G interactions.
The Western analyses with mutant infected lysates did suggest
lower levels of 2A were present in these cells, especially for the
LI134AA mutation (Fig. 4 BC, “Lysate” lanes). If true, 2A-dependent
mechanisms invoking an overall reduction in viral protein synthesis,
enhanced 2A turnover rates or a consequent defect in host-protein
shutoff schemes might be consistent with the observed slower plaque
development for these mutant viruses (Fig. 6A). Surprisingly, cells
pulsed with 35S-Met at 7 h PI labeled the full panel of non-2A viral
proteins at roughly equivalent levels (Fig. 5A), and moreover
indicated that effective host translational shutoff was readily achieved
by these mutants as well as the wild-type virus. Infected lysates
probed with virus-speciﬁc antibodies after 4 and 7 h PI, conﬁrmed
these observations (Fig. 6B). The viral polymerase 3D, and capsid
proteins 1AB and 1D, gave similar signals for all 3 viruses. The
diminished 2A mutant signals (Fig. 4) were protein-speciﬁc, because
2A but not its precursor P12A, was of lesser intensity only in the
double mutation sample.
The NLS motif
The mechanism by which 2A protein enters nuclei and accumulates
within nucleoli is unknown. A conserved region centering around
residue R97 matches the consensus pattern for yeast ribosomal protein
nucleolar localization signals, specialized derivatives of monopartitate
NLS (Fig. 2). The activities of this region were probed with single (R95A,
R97E, Q105A), double (YY92AA) and triple (KRRNAAA) point substitu-
tions with the intention of targeting positive-charged or highly
conserved residues (Fig. 7A). Additional deletion viruses excising the
full NLSmotif (Δ94–100) or the central portion of the protein (Δ40–97)
Fig. 2. 2A proteins. Cardiovirus 2A protein sequences (Table 2) encoding the putative NLS and eIF4E binding sites are aligned relative to known eIF4E binding sequences and yeast
ribosomal protein NLS (YRS-NLS) sequences (Gritz et al., 1985; Moreland et al., 1985; Schaap et al., 1991; Underwood and Fried, 1990). The eIF4E binding motifs are reviewed in
(Rhoads, 2009).
Fig. 3. Afﬁnity assays. Clariﬁed lysates were prepared from mock-infected or infected
HeLa cells (vEC9, MOI of 30), harvested 5 h PI. A. Agarose-conjugated eIF4E antibody
was added to a portion of each lysate and the bound proteins identiﬁed by Western
analyses with the indicated reagents. “Lysate” is a diluted (10%) starting sample
without resin fractionation. B. Similar to A, except resin was sepharose conjugated to
7me-GTP (cap). The bound and unbound proteins from the same lysate samples were
analyzed in parallel. C. Similar to A except the sepharose resin was conjugated to GMP.
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genome RNAs or derivative virus, although their growth characteristics
fell into different categories (Fig. 7A). The Q105A mutant behaved likeFig. 4. Mutations in eIF4E binding site. A. Recombinant substitution mutations in the
putative eIF4E-binding site are mapped. Wild-type virus (vEC9) or virus encoding the
single (L134A) or double (LI134AA)mutations were infected into HeLa cells. Lysates were
harvested and reacted with α-eIF4E resin (B) as in Fig 3A, or with 7me-GTP resin (C) as
in Fig 3B. “M” samples are from mock-infected cells carried in parallel.
Fig. 5. Protein synthesis during infection. A. Infected (vEC9) and uninfected (M) L-929 cells were pulse-labeled with 35S-methionine then harvested at 5 h PI. B. Similar to A, vEC9 and
viruses encoding the single (L134A) or double (LI134AA) 2A point mutations were infected into HeLa cells (MOI of 100). At 6 h PI the cells were treated with 35S-methionine and then
harvested 1 h later. C. Similar to B, HeLa cells were infected with vEC9 or the Δ94–100 and Δ40–97 NLS deletion mutant viruses, then pulsed with 35S-methionine 30 min before
harvest, at 4 h or 7 h PI. For all samples, the proteins were fractionated SDS-PAGE and visualized by phosphoimaging.
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developed plaques within 29 h, but their growth titer was about 5- to
10-fold lower and their plaque sizes were a bit smaller than wild-type.
The deletion viruses and KRRNAAA viruses proved difﬁcult to grow.
They required at least 48 h for visible plaques, with the larger deletion
having the most severe phenotype. Virus titers for all of these averaged
about 100 fold lower than vEC9.
Characteristics of the large Δ40–97 deletion during infection
of BHK cells have been described (Svitkin et al., 1998). The
mutant polyprotein is poorly expressed and has inefﬁcient primary
processing. Because of this, or in addition to these phenotypes, Δ40–
97 is defective in host translational shutoff. The same parameters held
true in HeLa cells (Figs. 5C and 7C), and moreover were displayed in
part by the much smaller Δ94–100 deletion excising only the putative
NLS region. When pulsed with 35S-Met 30 min prior to harvest
(Fig. 5B), both deletion mutants showed a decreased ability to inhibit
cap-dependent protein synthesis relative to vEC9, as evidenced by the
continued strong presence of non-viral background bands, even as
late as 7 h PI. Both deletions also had delayed P1/2A processing,
showing stronger precursor bands (e.g. P12A, 1CD2A, 1D2A) and
diminished mature capsid bands (1AB and 1D) at 4 h PI (Fig. 7C).
Primary and secondary processing was occurring, however, because
by 7 h PI, despite the continued presence of P1 precursors, 1AB, 1D
and free 2A were also detected. The very small Δ40–97 2A (b8 kDa) is
not retained on these gels, but it does contain epitopes recognized by
the mAb used in these assays. As a rule, the tested point mutations
including KRRNAAA did not show the same processing delays. Mature
capsid proteins and 2A appeared in a timeframe similar to vEC9 (all
mutants not shown) but the lower overall fecundity of the more
severe mutations (e.g. YY92AA, KRRNAAA) reduced the total yield of
2A.
NLS contribution to 2A localization
When infected into cells each of NLS region point mutants showed
2A nucleolar staining, although not necessarily as bright or persistent
as that induced by vEC9 (Fig. 1B). In contrast both deletion mutants
had almost exclusively cytoplasmic 2A signals, even at late time points(8 h PI), when their delayed processing allowed for mature proteins
(Fig. 7C). Only when multiple cell ﬁelds were examined were oc-
casional examples with slight nuclear staining observed for the
deletion mutants (e.g. Fig. 1B). The weaker patterns were always less
distinct than the strong punctuate nucleolar staining by vEC9, or even
the point mutants. Sub-cellular fractionation studies and Western
analysis conﬁrmed the results obtained by microscopy (not shown).
Certainly, active nuclear transport or passive diffusion across the
NPC have equivalent potential to give the same apparent nuclear
phenotypes for a protein as small as 2A. Discrimination between these
mechanisms used a test sensitive to active transport, using a larger
protein reporter. The 2A sequence was subdivided (codons 1–50, 51–
100, 101–143) then linked in-frame to an eGFP gene within an
expression cDNA (Fig. 8A). The variants were sequenced to conﬁrm
their identity, especially at the fusion junction. Western analyses after
transfection of HeLa cells gave strong signals for eGFP and for the
fusions with 2A1–50 and 2A51–100 (Fig. 8C). Reporters linked to full-
length 2A or the COOH-terminal 2A fragment (2A101–143) expressed
below the detection limit of this antibody (Fig. 8C). Localization of the
fusion proteins within transfected cells therefore relied on live cell
imaging of eGFP ﬂuorescence. The parent protein (eGFP) was found to
be distributed in both the nucleus and cytoplasm (Fig. 8B). Linkage to
2A1–50 did not signiﬁcantly change this distribution, with the ﬂuo-
rescent signal showing evenly throughout the cytoplasm and nucleus.
In the cytoplasm eGFP-2A1–50 in some cells localized to discrete foci
that were not present during viral infection and are likely an ac-
cumulation phenomenon due to the inability of 2A51–100 to efﬁciently
localize to nuclei. In a few cells, eGFP-2A1–50 demonstrated marginal
nucleolar localization. However, these cells were uncommon and
diffuse nuclear cytoplasmic distribution was the more representative
phenotype as evidenced by subcellular fractionation (Fig. 8C). Linkage
of eGFP to the 2A51–100 fragment converted the pattern into almost
exclusively nuclear but the protein was still excluded from the
nucleolus. For eGFP, eGFP-2A1–50 and eGFP-2A51–100, there was
sufﬁcient GFP antibody signal to conﬁrm the distributions by
subcellular fractionation andWestern analyses (Fig. 8C). As suggested
by the distributions within live cells, the relativeWestern signals (N/C
ratio) measured about a 5-fold higher in the nucleus with the 2A51–100
Fig. 6. Point mutation phenotypes. A. Wild-type virus (vEC9) and those encoding the
single (L134A) or double (LI134AA) 2A mutations were infected into HeLa cells. Plaques
were visualized at 29 or 48 h PI. B. Matched samples of infected or mock-infected cell
lysates were harvested at 4 h or 7 h PI, fractionated by SDS-PAGE, then subjected to
Western analyses using the indicated reagents.
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eGFP-2A and eGFP-2A101–143 fusion proteins , although adequate
recording of these signals required increased exposure (2×) and gain
(4×) relative to the other tested (less toxic) samples. Clearly, the full
2A fusion redirected eGFP from the cytoplasm into the nucleus, and
looked very much like the 2A51–100 signals with the exception of
accumulation of full length 2A in the nucleolus. Reporter linkage to
2A101–143 had the opposite effect, rendering the protein almost
exclusively cytoplasmic. The different phenotypes for all these
proteins are consistent with the idea that full length 2A, or 2A51–100
have NLS-like sequences inﬂuencing protein accumulation in the
nucleus, independent of diffusion.
Cell protein response to infection
Nuclear sequestration of eIF4E is one possible model by which the
2A NLS and the 2A factor-binding motif could potentially exert linked
activities. When tested in cells however, this simple hypothesis could
not be substantiated. Nuclear and cytoplasmic extracts from infectedor uninfected cells (4 h PI) gave no indication of eIF4E redistribution
(Fig. 9A). The infected extracts did have stronger nuclear 2A than
cytoplasmic 2A signals, as expected. But the eIF4e, eIF2α and tubulin
signals were predominantly cytoplasmic and remained so after
infection. Likewise, there was no infection-induced relocalization of
B23 (nucleolin) or eIF3n, a cytosolic ribosome dissociation factor.
Although experiments of this type cannot characterize every
cellular protein, we also monitored reagents peripheral to the 4E-BP1
pathways, since 2A competition for eIF4E binding is another potential
mechanism for host-translational shutoff activities. Reports that 4E-
BP1 becomes hypophosphorylated in a 2A-dependent manner after
infection of BHK cells with EMCV-R (Svitkin et al., 1998) were not
supported by our results in HeLa and L cells (Fig. 9B). With an
appropriate antibody, the four mTOR-induced 4E-BP1 phosphoryla-
tion states are readily distinguished inWestern assays (Mothe-Satney
et al., 2000). Whole cell extracts from our experiments showed no
signiﬁcant shift in the distribution of these states following infection
with vEC9 for either cell type (lanes 1 vs 3). Control cells deprived of
serum for 48 hours (starved) did indeed dephosphorylate 4E-BP1 in
HeLa but not L cells (lanes 3), a status that could be reversed when
serum was re-added (lanes 4). Parallel infections with 35S-Met pulse-
labeled HeLa and L cells, afﬁrmed that host-protein synthesis was in
fact shutoff in both cell types (Fig. 5A and B), but without triggering
apparent changes in the 4E-BP1 proﬁle. It is of interest that mTOR
kinase, the reactive agent controlling the phosphorylation status of
4E-BP1 did partially relocalize to the nucleus during vEC9 infection
(Fig. 9A). Moreover, there were additional changes in the phosphor-
ylation status of eIF4E, S6 and S6 kinase (S6K).
Discussion
Each of the 12 genera of picornaviruses encode one or more mid-
polyprotein genes designated "2A". Seven of the genera also encode
N-terminal Leader proteins, which work in synergy with 2A, to confer
a variety of anti-host defensive properties to genomes that contain
them. The 2A and L of cardioviruses are neither homologs nor analogs
to the other genera, and even among cardioviruses, these proteins
have variable sequences. The structure of EMCV L was recently
resolved (Cornilescu et al., 2008). Parallel function studies assigned its
potent cellular toxicity to nucleocytoplasmic trafﬁcking disruption,
mediated by aberrant L-induced MAPK cellular phosphorylation
cascades directed at NPC nucleoporin proteins and related cellular
targets (Porter et al., 2006; Porter and Palmenberg, 2009).
Studies on the cardiovirus 2A protein are not nearly as advanced.
When introduced independently into cells via cDNA, 2A is highly
inhibitory to self-expression from cap-containing mRNAs (Fig. 8C).
Unfortunately, the consequent corollary is that low protein yields
make it hard to follow what's actually happening in compromised
cells. Expression-competent mutant 2A sequences from equivalent
cDNAs, are by deﬁnition defective in 2A toxicity, and therefore less
than helpful for many experiments. Switching research tactics to virus
mutation studies creates additional technical problems. The C-
terminus of 2A is required for primary polyprotein processing. If
this sequence or its function are interfered with, the resulting L-P1-2A
region is not recognized or cleaved by 3Cpro (Hahn and Palmenberg,
1996, 2001). In turn, this means the P1 capsid proteins are cleavage-
defective and assembly incompetent, the L protein is not released for
its anti-cellular activities, 2B lacks a proper N-terminus to be func-
tional in replication complexes, and the compromised 2A may or may
not be released for nucleolar trafﬁcking and its own unspeciﬁed tasks.
Virus failure at any of these points can be lethal, or at a minimum give
small plaque phenotypes, perhaps erroneously assigned to "2A
function" instead of the mechanistically simpler, malfunction of co-
translational ribosome skipping. As an example, a key study linking
the 4E-BP1 phosphorylation status to 2A function, was based on
data suggesting rapamycin and wortmannin, mTOR inhibitors, could
Fig. 7. Mutations in NLS. A. Recombinant vEC9 with single (R95A, R97E, Q105A), double (YY92AA), triple (KRRNAAA) point mutations, and 7 (Δ94–100) or 58 (Δ40–97) amino acid
deletions in the 2A protein, spanning the putative NLS site were constructed. Italics denote residues changes relative to vEC9. B. The viruses were infected into HeLa cells at the
indicated dilutions. Plaques were visualized at 29 or 48 h PI. C. Matched samples of infected (MOI of 10) or mock-infected HeLa lysates were harvested at 4 h or 7 h PI, fractionated by
SDS-PAGE, then subjected to Western analyses using the indicated reagents.
263R. Groppo et al. / Virology 410 (2011) 257–267rescue a 2A-mutated virus, defective in cap-dependent shutoff
(Svitkin et al., 1998). We now know the virus used in those studies,
2AΔ58 (i.e. 2AΔ40–97) has signiﬁcant processing delays (Fig. 7C), tying
up the L protein in a precursor form and preventing its required
activities. In other words, for this particular deletion, rapamycin could
have rescued L instead of 2A pathways, and we would not have
distinguished a functional difference.
That 4E-BP1 is involved in 2A mechanisms remains an intriguing
hypothesis. We did not detect changes in this factor's phosphorylation
status during vEC9 infections in HeLa or L cells. On the other hand, it
cannot be fortuitous that 2A sequences mimic the eIF4E binding
motifs of 4E-BP1 and eIF4G (Fig. 2), another required factor for cap-
dependent translation. Antibody beads and 7meGTP-resins speciﬁc for
eIF4E, each pulled 2A out from infected cell extracts, suggesting direct
motif-protein contacts rather than third-party connections. Single or
double point mutations within this motif did not compromise
polyprotein processing patterns (Fig. 6B), but the resultant 2A was
only poorly reactive with eIF4E. Therefore, this site must be active and
somehow relevant to the 2A protein. Viruses with these mutationsgrew slower than vEC9 (Fig. 6B), although surprisingly, they were still
effective at the shut off of cap-dependent cellular translation (Fig. 5B).
For eIF4E, 4E-BP1, and perhaps also 2A, cellular localization may
provide a key to functionality. The role of eIF4E can vary depending on
its location (Culjkovic et al., 2007).When sited in the cytoplasm, eIF4E
functions in translation initiation. Its availability as an intermediate
between 5' cap recognition and eIF4G is regulated by the phosphor-
ylation status of 4E-BP1. In the nucleus, amuch smaller pool of eIF4E is
responsible for export of mRNAs containing 4E-sensitive elements
(SE) (Culjkovic et al., 2008, 2005). Normally, the special RNAs with SE
elements (e.g. cyclinD1), are under tight regulation and inefﬁciently
transported through the NPC without concomitant eIF4E interactions
(Culjkovic et al., 2005). Over-expression of eIF4E deregulates these
mRNA pools, creating potent cell cycle abnormalities, cell transfor-
mation, and typically correlates with a poor outcome in certain
cancers (Culjkovic et al., 2007).
Conceivably, if the relevant form of 2A:eIF4E interactions were
nuclear and not cytoplasmic, it might explain some of our observed
phenomena. 2A accumulates in the nucleus, preferentially in nucleoli
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disruption of 2A:eIF4E interactions had little effect on the shutoff of
cap-dependent translation initiation, nor did it affect virus IRES-
dependent translation, consistent with idea that 2A exerts its
inﬂuence in the nucleus or nucleolus, rather than cytoplasm. The
bulk of eIF4E (cytoplasmic), did not relocalize to nuclei after infection
(Fig. 9A), and in our cell types, the 4E-BP1 phosphorylation status did
not change sufﬁciently to account for cytoplasmic sequestering
(Fig. 9B). These results all point to an undeﬁned role for 2A:eIF4E
interactions outside of canonical cytoplasmic translation initiation.
Within the virus motifs we explored by mutation, only those
which prevented nucleolar accumulation of 2A were defective in host
translational shutoff. Nucleolar localization requires a protein to gain
nuclear access through an NLS or by passive diffusion, then to be
targetedmore speciﬁcally to nucleoli with auxiliary sequence patterns
(NoLS) providing retention interactions with nucleolar component
such as DNA, RNA or resident proteins. Cardiovirus 2A amino acids
90–100, form a conserved motif closely resembling the NLS and NoLS
used by yeast ribosomal proteins (Fig. 2). Single, double or even triple
charge change mutations in this motif gave smaller plaque viruses
(Fig. 7B) without causing signiﬁcant primary processing defects. But
unexpectedly, these 2A proteins still accumulated in nucleoli (Fig. 1B).Only excision of the full motif (i.e. 2AΔ94–97) prevented this lo-
calization pattern, and by extension, prevented shutoff of cap-
dependent translation (Fig. 5B). As with the larger 2AΔ40–97 deletion,
even the precise motif excision deletion was severely defective in
virus growth and had delayed L-P1-2A processing (Fig. 7C). Therefore,
assigning unambiguous 2A motif culpability requires the same
analytical caveats as the previously reported 4E-BP1 experiments
(Svitkin et al., 1998). Namely, we can't be absolutely sure if the
cellular cap-shutoff phenotypes of these particular deletions were
imposed because of, or in spite of their 2A NLS locations.
As a start towards this answer, we subdivided the 2A sequence,
linked each fragment to eGFP then asked whether the resulting fusion
could drive the reporter into nuclei after cDNA transfection. Full-length
2A and the 51–100 fragment encoding the putative NLS, both had this
property, but only the full-length protein (2A-linked) was strongly
nucleolar. Independently, the NH2- and COOH 2A fragments were
ineffective for sustained relocalization. This identiﬁes the central 2ANLS
motif (94–100) as active under conditions where nucleocytoplasmic
trafﬁcking is functional (i.e. early during viral infection or after
transfection of cDNA). Nucleolar retention however, must require
additional 2A sequences. Since the protein needs to gain nuclear access
(NLS or diffusion) then stick there, we suspect there must be additional
Fig. 9. Subcellular Protein Distribution. A. Infected (+, vEC9, MOI of 30) and uninfected
(−) HeLa cells were harvested at 4 h PI. Equivalent cell counts for whole cell extracts
(Whole), cytoplasmic (Cyto) or nuclear (Nuc) extracts were gel fractionated, then
subjected to Western analyses using the indicated reagents. B. Infected (lane 2, vEC9,
MOI of 100) or uninfected (lane 1) HeLa cells or L-929 cells were harvested at 5 h PI,
fractionated by SDS-PAGE then probed by Western analyses for 4E-BP1 phosphoryla-
tion status. P+ indicates hyper-phosphorylation, P− indicates hypo-phosphorylation.
Control samples (lane 3) are from uninfected cells after serum starvation, or (lane 4)
from similarly starved cells, resupplemented with serum 1 h before harvest.
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identiﬁed (N-terminus?), a 2A functionality suggested by some of the
very original work on this protein (Medvedkina et al., 1974). We are
currently initiating further proteinmapping studies to identify whether
such a motif exists and if so, to describe its speciﬁcity.
Interestingly, the 101–143 fragment even when linked to eGFP
proved highly toxic to cDNA cap-dependent self-expression, as was
the full-length 2A-linked fusion. It cannot be a coincidence that this C-
terminal fragment, unique in sequence among picornaviruses,
contained the intact eIF4E binding motif. Perhaps the overall purpose
of cardiovirus 2A nucleolar targeting may be to deliver this toxic
segment to its required locale for disruption of nucleolar eIF4E
activities. If so, the recombinant eGFP-2A101–143 might have inadver-
tently depleted nuclei (cytosol?) of eIF4E, synthetically achieving the
same effect without nucleolar retention. To test this idea, we areattempting to devise better assays for all these proteins so we can
begin to follow the fates and phosphorylation status of nuclear eIF4E
during infection or transfection experiments. Sensitive methods to
measure rRNA synthesis and SE-containing mRNA fates when 2A is
(or is not) allowed nucleolar accumulation are also required.
Moreover, the potential role of L-induced MAPK phosphoryla-
tion cascades and/or cellular NPC trafﬁcking inhibition cannot be
discounted for possible synergy with 2A activities during infection.
The functional status of mTOR and 4E-BP1 are most certainly linked to
L-dependent regulation. The data we have presented here on the 2A
NLS and eIF4E binding motifs are just the most recent steps towards
unraveling these complicated mechanisms.
Materials and methods
Viruses and cells
HeLa cells (ATCC CCL-2) were grown in suspension culture with
modiﬁed Eagle's medium, 10% calf serum (NBCS) and 1% fetal bovine
serum (FBS). Virus vEC9 is a recombinant EMCV-R containing a
shortened poly-C tract (Hahn and Palmenberg, 1995). Cell or mouse
infections with this sequence or its mutant derivatives are well
described (Hoffman and Palmenberg, 1995; Martin et al., 1996).
Brieﬂy, subconﬂuent (90–95%) plated HeLa cells or L-929 cells were
washedwith phosphate buffered saline (PBS) then overlaid with virus
diluted in PBS. After an attachment period (30 min, 25 °C) Eagle's
medium containing 10% NBCS or 1×P5 (37 °C) was added and cells
were incubated (37 °C, 5% CO2). Plaque analysis was as described
(Dvorak et al., 2001). During experiments to measure 4E-BP1
phosphorylation status, some control (uninfected) cells were starved
of serum for 48 hours (induced hypo-phosphorylation), or starved
(48 h) then resupplemented with serum (1 h) before harvest
(induced hyper-phosphorylation) (Svitkin et al., 1998).
Subcellular fractionation
Infected (vEC9, MOI of 30) and uninfected HeLa cells were counted
(on plates) at 4 h PI, washed with PBS, harvested, resuspended in
buffer (10 mM Hepes, pH 7.7, 1.5 mM MgCl2, 10 mM KCl, 1 mM DTT,
1 mM PMSF) then incubated on ice for 15 min. Cells were pelleted
(400g), resuspended in buffer then lysed by passing through a 26 G
syringe (10×). A fraction of the whole cell lysate (Whole) was
retained. Nuclei were pelleted (10,000g, 10 min., 4 °C). The superna-
tant was saved as the cytoplasmic lysate (Cyto). The nuclei were
washed (3×, 10 mM Tris, pH 7.4, 2 mM MgCl2, 0.3 M sucrose),
repelleted, suspended in wash buffer then lysed by sonication (Nuc).
Samples normalized to contain equivalent cell counts were re-
suspended in loading buffer, boiled, fractionated by SDS-PAGE
(Laemmli) and analyzed in Western assays.
Recombinant constructions
Full-length recombinant EMCV genomes encoding single (L134A,
R95A, R97E, Q105A) double (LI134AA, YY92AA) or triple (KRRNAAA) 2A
point mutations or a 7 aa deletion (2AΔ94–100) were engineered using
the primers in Table 1 and standard cloning procedures. Positive-
sense primers for each mutation were added to PCR reactions along
with primer 526 and pEC9 cDNA. Similar reactions were performed
with corollary negative-sense mutagenic primers and primer 256. The
amplicons were combined then used as templates in secondary PCR
reactions with primers 526 and 256. The products were digested with
Sac I and Sac II (New England Biolab, NEB), as was the pEC9 cDNA.
Appropriate fragments were gel puriﬁed (agarose) then ligated (T7
ligase, NEB). Recombinant plasmid pE-2AΔ40–97 (previously, pEC9-
2AΔ58) has a deletion of 58 residues within 2A removing the middle
third of the protein (Svitkin et al., 1998).
Table 1
Primers used for 2A variants.
Primer Sequence
526 + TGGTAGTCGAAACCATCTGACAG
256 − GTTCCTCATTGCCTACAC
L134A 987 + GCGGACCTAGCGATTCATGACATTGAGACAAAT
L134A 988 − GTCATGAATCGCTAGGTCCGCAAAGTAACCAGCG
LI134AA 1080 + GACCTAGCGGCTCATGACATTGAGACAAAT
LI134AA 1081 − TGTCATGAGCCGCTAGGTCCGCAAGTAACC
R95A 711 + TATATATTATAAGGCAGTCAGGCCTTTTAGACTGC
R95A 712 − AAGGCCTGACTGCCTTATAATATATATCCATGG
R97E 560 + GAGAGTCGAGCCTTTTAGACTGCCCCTGG
R97E 561 − CAGTCTAAAAGGCTCGACTCTCTTATAATATATATCC
Q105A 562 + CTGGTTGCGAAGGAATGGCCCGTGCGAG
Q105A 563 − CATTCCTTCGCAACCAGGGGCAGTCTAAA
YY92AA 747 + TATAGCTGCTAAGAGAGTCAGGCCTTTTAG
YY92AA 748 − TCTCTTAGCAGCTATATCCATGGTCACTCTAC
KRRNAAA 743 + TATATTATGCGGCAGTCGCGCCTTTTAGACTGCCCCTGG
KRRNAAA 744 − AAAAGGCGCGACTGCCGCATAATATATATCCATGGTCAC
Δ94–100 745 + CATGGATATATATTATCTGCCACTGGTTCAGAAGGA
Δ94–100 746 − TTCTGAACAGTGGCAGATAATATATATCCATGGTCAC
peGFP 1206 + TGTAAATCCATGGGCGGCTCCCACCATCATCATCA-
TCATATGGTGAGCAAGGGCGAGGAGCTG
peGFP 1208 − GAGATCGGATCCCGGACTTGTACA
peGFP-2A 1211 + TGATGGTGGTGCTCGAGCTACCCT
peGFP-2A 1212 − CCGAAAAAGCTTTCCAAATGCCCTAGA
peGFP-2A1–50 1217 + GTTACCGAAAGCTTAGTCCAAAT
peGFP-2A1–50 1218 − CAGGAACTCGAGTTATTTGGTCTTTGATCT
peGFP-2A51–100 1219 + TCAAAGAAGCTTCAGGTCTCTTTCCTGAGC
peGFP-2A51–100 1220 − CTGAACCTCGAGTTATCTAAAGGCCTGACTCTCTT
peGFP-2A101–143 1221 + AAGCCTAAGCTTCTGCCCTGGTTCAGAAGGAA
266 R. Groppo et al. / Virology 410 (2011) 257–267Plasmid peGFPwas prepared by amplifying the eGFP gene from pt-
GFP (Mir and Panganiban, 2008) using primers 1206 and 1207. The
product amplicon was digested with Nco I and Bam HI, gel puriﬁed,
then ligated into pTriex-1.1 (Novagen) using the same restriction
sites. Plasmid peGFP-2A was from an EMCV 2A amplicon (primers
1211 and 1212), digested with Hind III and Xho I, then ligated into the
same sites of peGFP. Protein expression after plasmid transfection is
driven by a β-globulin promoter, and produces an abutted in-frame
fusion between eGFP and 2A . Plasmids peGFP-2A1–50, peGFP-2A51–100
and peGFP-2A101–143 are deletion derivatives created by the same
strategy, albeit with different primers (Table 1). Each encodes a full
eGFP but only the listed 2A amino acids. The insert conﬁgurations of
all cDNAs were conﬁrmed by sequence analysis.
Western assays
Denatured protein samples were fractionated by SDS-PAGE then
transferred onto PVDF membranes (Immobilon P, Millipore) using
transfer buffer MT (25 mM Tris, pH 8.0, 0.19 M glycine, 20% methanol).
After treatmentwith blocking buffer (5%w/v nonfat drymilk, 0.05%w/v
Tween-20 in TBS, 1 h, 20 °C), the membranes were rinsed with TBS
(20 mM Tris-HCl, pH 7.6, 140 mM NaCl) and reacted overnight with
primary antibody (in TBS with 2.5% w/v nonfat dry milk, 0.05% w/v
Tween-20 in TBS) at 4 °C with agitation. The membranes were rinsed
(3×, TBS) and treated with horseradish peroxidase-conjugated second-
ary antibody (inMT), then rinsed (3×, TBS) again before the bandswere
visualized by chemiluminescence (ECL kit, Amersham Bioscience).
Murine monoclonals (5A12; 1:2000 dilution) against Mengo 2A
(Aminev et al., 2003a) and Mengo 3Dpo (8D10) as well as murine
polyclonal against the Mengo capsid (Frolov et al., 1999) have
been described. Polyclonal antibodies against tubulin, GFP, eIF3n,
B23 (1:1000, Santa Cruz Biotech), S6, eIF4E, 4E-BP1, eIF2α and
phosphospeciﬁc antibodies against S6, S6K, eIF4E and Mnk1 (1:1000,
Cell Signaling Technology) were commercial, as were appropriate
secondary antibodies (1:8000) and stains for WGA (rhodamine or
ﬂuorescein) andDAPI (Sigma).Onallﬁgures “α”designates the target of
the primary antibody.Confocal microscopy
HeLa cells (7×105) grown on coverslips in 30 mm dishes or in 24
well plates were infected with virus (MOI of 10 PFU/cell). For
transfection experiments, the cells (2.2×105 cells/well), were reacted
with Lipofectamine 2000 (Invitrogen) and appropriate cDNAs (1:1, μg
cDNA/Lipofectamin), puriﬁed using Maxi-Prep techniques (Qiagen).
At the time of harvest (24 h for transfections), cells were washed (2×,
PBS), ﬁxed for 10 min at room temperature with 4% formaldehyde,
washed again (3×, PBS) and permeabilized (0.2% Triton, 5 min, 25°C).
After further washing (3×, PBS), blocking solution (10% FBS in TBS)
was added (1 h at 25°C), followed by anotherwash (1×, TBS). The cells
were reacted with primary antibody (diluted with 3% FBS in TBS)
overnight at 4°C, then rewashed (3×, TBS) before the secondary
antibody, WGA (rhodamine-conjugated or ﬂuorescein-conjugated)
and/or DAPI (diluted in 3% FBS in TBS) were added (1 h, room
temperature). After a ﬁnal wash (3×, TBS) the samples and mounted
on slides using Vectorshield mounting media (Vector Labs). Visuali-
zation used a Nikon Eclipse TE2000-V laser scanning confocal
microscope with excitation lines of 408 (blue), 488 (green) and 543
(red) nM. EZ-CL1 and Photoshop softwarewas used for image analysis.
eIF4E afﬁnity assays
Infected HeLa cells (vEC9, MOI of 30) were harvested 5 h PI,
washed with PBS then resuspended in IP buffer (20 mM Tris-HCl pH
7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 1 mM
beta-glycerol phosphate, 1 mM Na3VO4, 1 mM PMSF). After 5 min on
ice, samples were lysed by sonication (3×, 5 s) and clariﬁed by
centrifugation (4 °C, 10 min., 14,000× g). Protein concentrations were
determined (Bio-Rad assay) and equivalent total protein samples
were reacted with anti-eIF4E antibody conjugated to agarose beads
(~20 μl, Santa Cruz Biotech). After incubation (16 h, 4 °C) the beads
were washed extensively (1× TBS), then boiled in SDS, before the
collected proteins were fractionated by SDS-PAGE and visualized by
Western analyses.
Cap afﬁnity assays
Infected cells were collected, washed with PBS then resuspended
in buffer C (20 mM Tris, pH 7.4, 100 mM KCl, 20 mM beta-glycerol
phosphate, 1 mM DTT, 0.25 mM Na3VO4, 10nM NaF, 1 mM EDTA,
1 mM EGTA, 10 nM okadaic acid, 1 mM PMSF) before being subjected
to 3× freeze/thaw cycles. Samples were clariﬁed by centrifugation
(10,000g, 4 °C, 10 min). Protein concentrations were determined
(Bio-Rad assay) and equivalent total protein samples were reacted
with 7meGTP-sepharose 4B resin (~30 μl, GE Healthcare) or GMP-
agarose resin (Sigma) for 3 h, 4 °C before the resin samples were
extensively washed with buffer C then boiled in SDS, before the
collected proteins were fractionated by SDS-PAGE.
Metabolic labeling
Conﬂuent HeLa monolayers (30 mm plates) were infected with
virus (MOI of 100 PFU/cell). After an attachment period (30 min,
20 °C) the plates were washed (2×, PBS) then overlaid with P5
medium (Rueckert and Pallansch, 1981). Ninety minutes prior to
harvest the monolayers were washed again (2×, PBS) then overlaid
with MEM lacking methionine (Sigma). One hour later, [35S]-Met was
added (100 μCi/plate, Amersham), and after an additional 30 min, the
cells were washed (2×, PBS) and lysed (30 mM Tris–HCl, pH 7.4,
140 mM NaCl, 0.5% NP-40). The incorporation of label into acid-
insoluble material was quantiﬁed by scintillation counting. The
protein content was visualized by autoradiography after fractionation
by SDS-PAGE.
Table 2
Cardiovirus sequences.
Sequence GeneBank accession number
TMEV (GDVII) P08545
Theiler's-like virus of rats BAC58035
Mengo virus (M) P12296
EMCV (B) P17593
Human TMEV-like cardiovirus YP_001950226
Saffold virus YP_001816886
EMCV (vEC9) P03304
267R. Groppo et al. / Virology 410 (2011) 257–267Bioinformatic analysis
Cardiovirus genome sequences are available from NCBI (Table 2).
The 2A protein alignment used MEGA software (Tamura et al., 2007)
with Blosum matrix settings, a gap opening penalty of 3 and gap
extension penalty 1.8. The output ﬁle was examined and adjusted for
high and low road considerations consistent with the biology of these
proteins.
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